Cas no 73665-15-3 ([(2R,3R,6E,8S,9S,10S,12R,14E)-3-ethyl-8,10,12-trimethyl-5,13-dioxo-9-{[3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl]oxy}-4,17-dioxabicyclo[14.1.0]heptadeca-6,14-dien-2-yl]methyl 6-deoxy-2,3-di-O-methyl-beta-D-allopyranoside)
73665-15-3 structure
Product Name:[(2R,3R,6E,8S,9S,10S,12R,14E)-3-ethyl-8,10,12-trimethyl-5,13-dioxo-9-{[3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl]oxy}-4,17-dioxabicyclo[14.1.0]heptadeca-6,14-dien-2-yl]methyl 6-deoxy-2,3-di-O-methyl-beta-D-allopyranoside
CAS No:73665-15-3
MF:C37H61NO12
MW:711.879752874374
CID:1761788
PubChem ID:6447308
Update Time:2024-03-02
[(2R,3R,6E,8S,9S,10S,12R,14E)-3-ethyl-8,10,12-trimethyl-5,13-dioxo-9-{[3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl]oxy}-4,17-dioxabicyclo[14.1.0]heptadeca-6,14-dien-2-yl]methyl 6-deoxy-2,3-di-O-methyl-beta-D-allopyranoside Chemical and Physical Properties
Names and Identifiers
-
- [(2R,3R,6E,8S,9S,10S,12R,14E)-3-ethyl-8,10,12-trimethyl-5,13-dioxo-9-{[3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl]oxy}-4,17-dioxabicyclo[14.1.0]heptadeca-6,14-dien-2-yl]methyl 6-deoxy-2,3-di-O-methyl-beta-D-allopyranoside
- LogP
- [(2R,3R,6E,8S,9S,10S,12R,14E)-3-ethyl-8,10,12-trimethyl-5,13-dioxo-9-{[3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl]oxy}-4,17-dioxabicyclo[14.1.0]heptadeca-6,14-dien-2-yl]methyl 6-deoxy-
- 73665-15-3
- A 11725 I
- (2R,3R,6E,8S,9S,10S,12R,14E)-9-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-3-ethyl-2-((((2R,3R,4R,5R,6R)-5-hydroxy-3,4-dimethoxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)methyl)-8,10,12-trimethyl-4,17-dioxabicyclo[14.1.0]heptadeca-6,14-diene-5,13-dione
- Antibiotic AR 5-1
- (2R,3R,6E,8S,9S,10S,12R,14E)-9-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-3-ethyl-2-[[(2R,3R,4R,5R,6R)-5-hydroxy-3,4-dimethoxy-6-methyloxan-2-yl]oxymethyl]-8,10,12-trimethyl-4,17-dioxabicyclo[14.1.0]heptadeca-6,14-diene-5,13-dione
- Mycinomycin I
- Mycinamicin I
- C18845
- Q27155686
- CHEBI:82006
- Antibiotic A 11725I
-
- Inchi: 1S/C37H61NO12/c1-11-27-24(18-45-37-35(44-10)34(43-9)30(41)23(6)47-37)33-28(49-33)14-13-26(39)20(3)16-21(4)32(19(2)12-15-29(40)48-27)50-36-31(42)25(38(7)8)17-22(5)46-36/h12-15,19-25,27-28,30-37,41-42H,11,16-18H2,1-10H3/b14-13+,15-12+/t19-,20+,21-,22+,23+,24+,25-,27+,28?,30+,31+,32+,33?,34+,35+,36-,37+/m0/s1
- InChI Key: QABCJBNUVVMWAL-HXRJSAKRSA-N
- SMILES: O1C2C=CC([C@H](C)C[C@H](C)[C@@H]([C@@H](C)C=CC(=O)O[C@H](CC)[C@@H](CO[C@H]3[C@@H]([C@@H]([C@@H]([C@@H](C)O3)O)OC)OC)C12)O[C@H]1[C@@H]([C@H](C[C@@H](C)O1)N(C)C)O)=O |t:2,13|
Computed Properties
- Exact Mass: 711.41937638g/mol
- Monoisotopic Mass: 711.41937638g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 2
- Hydrogen Bond Acceptor Count: 13
- Heavy Atom Count: 50
- Rotatable Bond Count: 9
- Complexity: 1170
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 15
- Undefined Atom Stereocenter Count : 2
- Defined Bond Stereocenter Count: 2
- Undefined Bond Stereocenter Count: 0
- XLogP3: 3
- Topological Polar Surface Area: 155?2
[(2R,3R,6E,8S,9S,10S,12R,14E)-3-ethyl-8,10,12-trimethyl-5,13-dioxo-9-{[3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl]oxy}-4,17-dioxabicyclo[14.1.0]heptadeca-6,14-dien-2-yl]methyl 6-deoxy-2,3-di-O-methyl-beta-D-allopyranoside Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| SHANG HAI TAO SHU Biotechnology Co., Ltd. | T28121-5 mg |
Mycinamicin I |
73665-15-3 | 5mg |
¥7000.00 | 2023-03-24 | ||
| SHANG HAI TAO SHU Biotechnology Co., Ltd. | T28121-5mg |
Mycinamicin I |
73665-15-3 | 5mg |
¥ 7000 | 2023-09-07 |
[(2R,3R,6E,8S,9S,10S,12R,14E)-3-ethyl-8,10,12-trimethyl-5,13-dioxo-9-{[3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl]oxy}-4,17-dioxabicyclo[14.1.0]heptadeca-6,14-dien-2-yl]methyl 6-deoxy-2,3-di-O-methyl-beta-D-allopyranoside Related Literature
-
Manickam Bakthadoss,Tadiparthi Thirupathi Reddy,Vishal Agarwal,Duddu S. Sharada Chem. Commun., 2022,58, 1406-1409
-
Kay S. McMillan,Anthony G. McCluskey,Annette Sorensen,Marie Boyd,Michele Zagnoni Analyst, 2016,141, 100-110
-
Qiaoe Wang,Meiling Lian,Xiaowen Zhu,Xu Chen RSC Adv., 2021,11, 192-197
-
Fereshteh Bayat Environ. Sci.: Nano, 2021,8, 367-389
73665-15-3 ([(2R,3R,6E,8S,9S,10S,12R,14E)-3-ethyl-8,10,12-trimethyl-5,13-dioxo-9-{[3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl]oxy}-4,17-dioxabicyclo[14.1.0]heptadeca-6,14-dien-2-yl]methyl 6-deoxy-2,3-di-O-methyl-beta-D-allopyranoside) Related Products
- 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
- 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
- 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
- 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
- 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
- 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
- 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
- 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
- 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
- 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)
Recommended suppliers
Henan Dongyan Pharmaceutical Co., Ltd
Gold Member
CN Supplier
Bulk
煙臺朗裕新材料科技有限公司
Gold Member
CN Supplier
Reagent
Jiangsu Xinsu New Materials Co., Ltd
Gold Member
CN Supplier
Bulk
Shanghai Pearlk Chemicals Co., Ltd.
Gold Member
CN Supplier
Bulk
Amadis Chemical Company Limited
Gold Member
CN Supplier
Reagent